Literature DB >> 26391245

[New aspects for staging and grading of tumor metastases].

C Wittekind1.   

Abstract

Modern therapeutic regimens have improved the prognosis of patients with metastatic tumours. This requires a subclassification of metastases with more categories than M0 versus M1/pM1. For some tumour entities UICC proposals exist for a subclassification of metastases: colorectal cancer, lung cancer, malignant bone tumours, malignant melanoma and Merkel cell carcinomas of skin, as well as uterine and prostate cancer. Metastases are graded according to the same principles as the corresponding primary tumours. Differences in the grade between primary tumour and metastases have been described without evident differences in prognosis. Recent reports showed a similar prognosis for colorectal carcinoma liver metastasis resected R0 or R1. In a certain percentage of R1 resections an inconsistent use of the R classification as to R1 may be responsible.

Entities:  

Keywords:  Grading; Metastases; Oligometastases; Prognosis; R classification

Mesh:

Year:  2015        PMID: 26391245     DOI: 10.1007/s00292-015-0070-7

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  14 in total

1.  The impact of margins on outcome after hepatic resection for colorectal metastasis.

Authors:  Chandrakanth Are; Mithat Gonen; Kathleen Zazzali; Ronald P Dematteo; William R Jarnagin; Yuman Fong; Leslie H Blumgart; Michael D'Angelica
Journal:  Ann Surg       Date:  2007-08       Impact factor: 12.969

2.  Medullary thyroid cancer: analyses of survival and prognostic factors and the role of radiation therapy in local control.

Authors:  J Brierley; R Tsang; W J Simpson; M Gospodarowicz; S Sutcliffe; T Panzarella
Journal:  Thyroid       Date:  1996-08       Impact factor: 6.568

3.  Influence of margins on overall survival after hepatic resection for colorectal metastasis: a meta-analysis.

Authors:  Mashaal Dhir; Elizabeth R Lyden; Antai Wang; Lynette M Smith; Fred Ullrich; Chandrakanth Are
Journal:  Ann Surg       Date:  2011-08       Impact factor: 12.969

4.  The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours.

Authors:  Peter Goldstraw; John Crowley; Kari Chansky; Dorothy J Giroux; Patti A Groome; Ramon Rami-Porta; Pieter E Postmus; Valerie Rusch; Leslie Sobin
Journal:  J Thorac Oncol       Date:  2007-08       Impact factor: 15.609

5.  R1 resection by necessity for colorectal liver metastases: is it still a contraindication to surgery?

Authors:  Robbert J de Haas; Dennis A Wicherts; Eduardo Flores; Daniel Azoulay; Denis Castaing; René Adam
Journal:  Ann Surg       Date:  2008-10       Impact factor: 12.969

Review 6.  Histopathological evaluation of resected colorectal cancer liver metastases: what should be done?

Authors:  Nikki Knijn; Jannemarie A M de Ridder; Cornelis J A Punt; Johannes H W de Wilt; Iris D Nagtegaal
Journal:  Histopathology       Date:  2013-06-13       Impact factor: 5.087

7.  Prognostic factors in 1,521 melanoma patients with distant metastases.

Authors:  A Barth; L A Wanek; D L Morton
Journal:  J Am Coll Surg       Date:  1995-09       Impact factor: 6.113

Review 8.  The process for continuous improvement of the TNM classification.

Authors:  Mary K Gospodarowicz; Daniel Miller; Patti A Groome; Frederick L Greene; Pamela A Logan; Leslie H Sobin
Journal:  Cancer       Date:  2004-01-01       Impact factor: 6.860

9.  Outcome of microscopic incomplete resection (R1) of colorectal liver metastases in the era of neoadjuvant chemotherapy.

Authors:  Ninos Ayez; Zarina S Lalmahomed; Alexander M M Eggermont; Jan N M Ijzermans; Jeroen de Jonge; Kees van Montfort; Cornelis Verhoef
Journal:  Ann Surg Oncol       Date:  2011-10-18       Impact factor: 5.344

10.  Novel insights of oligometastases and oligo-recurrence and review of the literature.

Authors:  Yuzuru Niibe; Joe Y Chang
Journal:  Pulm Med       Date:  2012-08-22
View more
  1 in total

1.  cR and pR: The Residual Tumor Classification Revisited.

Authors:  Arne Warth
Journal:  Pathol Oncol Res       Date:  2017-04-21       Impact factor: 3.201

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.